That I believe is part of this phase that has started with EAT COVID trial after completing the pre-clinicalmhase with 6 patients and seeing no adverse effect.
Please also see resent discussion, in this post Post #: 50525086, (and follow the few posts back in the thread). But always keen to know more if you can contribute please as my knowledge is more "learning along the way" so to speak (encouraged by my related field of work)
Ann: Immutep Corporate Presentation, page-4
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.005(1.47%) |
Mkt cap ! $501.1M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 33.5¢ | $932.8K | 2.725M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29411 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 938315 | 11 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |